Literature DB >> 17178405

Pacemaking by HCN channels requires interaction with phosphoinositides.

Gerd Zolles1, Nikolaj Klöcker, Daniela Wenzel, Jutta Weisser-Thomas, Bernd K Fleischmann, Jochen Roeper, Bernd Fakler.   

Abstract

Hyperpolarization-activated, cyclic-nucleotide-gated (HCN) channels mediate the depolarizing cation current (termed I(h) or I(f)) that initiates spontaneous rhythmic activity in heart and brain. This function critically depends on the reliable opening of HCN channels in the subthreshold voltage-range. Here we show that activation of HCN channels at physiologically relevant voltages requires interaction with phosphoinositides such as phosphatidylinositol-4,5-bisphosphate (PIP(2)). PIP(2) acts as a ligand that allosterically opens HCN channels by shifting voltage-dependent channel activation approximately 20 mV toward depolarized potentials. Allosteric gating by PIP(2) occurs in all HCN subtypes and is independent of the action of cyclic nucleotides. In CNS neurons and cardiomyocytes, enzymatic degradation of phospholipids results in reduced channel activation and slowing of the spontaneous firing rate. These results demonstrate that gating by phospholipids is essential for the pacemaking activity of HCN channels in cardiac and neuronal rhythmogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178405     DOI: 10.1016/j.neuron.2006.12.005

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  79 in total

1.  The expression and role of hyperpolarization-activated and cyclic nucleotide-gated channels in endocrine anterior pituitary cells.

Authors:  Karla Kretschmannova; Marek Kucka; Arturo E Gonzalez-Iglesias; Stanko S Stojilkovic
Journal:  Mol Endocrinol       Date:  2011-12-01

Review 2.  Exploring HCN channels as novel drug targets.

Authors:  Otilia Postea; Martin Biel
Journal:  Nat Rev Drug Discov       Date:  2011-11-18       Impact factor: 84.694

3.  The voltage dependence of I(h) in human myelinated axons.

Authors:  James Howells; Louise Trevillion; Hugh Bostock; David Burke
Journal:  J Physiol       Date:  2012-02-06       Impact factor: 5.182

4.  Properties and functional implications of I (h) in hippocampal area CA3 interneurons.

Authors:  Warren D Anderson; Emilio J Galván; Jocelyn C Mauna; Edda Thiels; Germán Barrionuevo
Journal:  Pflugers Arch       Date:  2011-09-21       Impact factor: 3.657

5.  Myristoylated peptides potentiate the funny current (I(f)) in sinoatrial myocytes.

Authors:  Zhandi Liao; Joshua R St Clair; Eric D Larson; Catherine Proenza
Journal:  Channels (Austin)       Date:  2011-03-01       Impact factor: 2.581

6.  HCN1 channels constrain synaptically evoked Ca2+ spikes in distal dendrites of CA1 pyramidal neurons.

Authors:  David Tsay; Joshua T Dudman; Steven A Siegelbaum
Journal:  Neuron       Date:  2007-12-20       Impact factor: 17.173

7.  alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents.

Authors:  David B Carr; Glenn D Andrews; William B Glen; A Lavin
Journal:  J Physiol       Date:  2007-08-16       Impact factor: 5.182

8.  The presence of pacemaker HCN channels identifies theta rhythmic GABAergic neurons in the medial septum.

Authors:  Viktor Varga; Balázs Hangya; Kinga Kránitz; Anikó Ludányi; Rita Zemankovics; István Katona; Ryuichi Shigemoto; Tamás F Freund; Zsolt Borhegyi
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

9.  Dendritic HCN channels shape excitatory postsynaptic potentials at the inner hair cell afferent synapse in the mammalian cochlea.

Authors:  Eunyoung Yi; Isabelle Roux; Elisabeth Glowatzki
Journal:  J Neurophysiol       Date:  2010-03-10       Impact factor: 2.714

10.  MPP(+) -dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons.

Authors:  A Masi; R Narducci; E Landucci; F Moroni; G Mannaioni
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.